Novartis drops asthma drug fevipiprant after trial failures
ZURICH (Reuters) – Swiss drugmaker Novartis on Monday said it is jettisoning what it had...
Read MoreDec 16, 2019
ZURICH (Reuters) – Swiss drugmaker Novartis on Monday said it is jettisoning what it had...
Read MoreDec 15, 2019
KUALA LUMPUR (Reuters) – Malaysia’s health authorities on Sunday said they are working with UNICEF to bring polio vaccines to the state of Sabah in Malaysian Borneo, where the country’s first polio case in...
Read MoreDec 14, 2019
By Will Ziebell MELBOURNE (Reuters) – The South Pacific island nation of Samoa on Saturday...
Read MoreDec 14, 2019
By Jan Wolfe (Reuters) – Bristol-Myers Squibb Co on Friday said it won a $752 million jury...
Read MoreDec 13, 2019
By Tamara Mathias and Michael Erman (Reuters) – Shares of Sarepta Therapeutics Inc...
Read MoreDec 13, 2019
By Lisa Rapaport (Reuters Health) – Adolescents who are active on social media may be more likely to exercise excessively, skip meals or develop other forms of disordered eating, a U.S. study suggests. Researchers surveyed...
Read MoreDec 13, 2019
(Reuters) – Independent advisers to the U.S. Food and Drug Administration on Friday voted unanimously in favor of Horizon Therapeutics Plc’s experimental treatment for active thyroid eye disease, taking the drug...
Read MoreDec 13, 2019
By Saumya Joseph (Reuters) – U.S. health regulators on Friday approved expanding the heart...
Read MoreDec 13, 2019
(Reuters) – Santa Anita Park, where 35 horses have died as the result of injuries in the...
Read MoreDec 13, 2019
By Linda Carroll (Reuters Health) – While army suicides have historically decreased during wartime, that trend appears to have reversed in recent decades, a new study of U.S. records finds. Researchers poring over nearly...
Read MoreDec 13, 2019
By Vishwadha Chander (Reuters Health) – (Reuters Health) – Terminally-ill patients who discussed their options for end-of-life care tended to survive longer than those who had not, a small clinical trial in Denmark...
Read MoreDec 13, 2019
By Julie Steenhuysen CHICAGO (Reuters) – The U.S. Food and Drug Administration on Friday granted approval for Tandem Diabetes Care’s software program that uses readings from a continuous glucose monitor to predict...
Read MoreDec 13, 2019
By Julie Steenhuysen (Reuters Health) – A new study adds to evidence that male and female scientists in Europe have very different perceptions of gender equality and that male researchers don’t recognize gender bias...
Read MoreDec 13, 2019
(This December 12 story corrects to Missouri from Montana in last paragraph) By Caroline Humer and Julie Steenhuysen NEW YORK (Reuters) – CVS Health Corp said on Thursday it will make it easier for patients with advanced...
Read MoreDec 13, 2019
By Saumya Joseph (Reuters) – Biogen Inc said on Friday it would discontinue the development of its experimental therapy for a rare brain disease after the treatment failed a mid-stage trial, the latest setback in attempts...
Read MoreDec 13, 2019
(Reuters) – Pfizer Inc said on Friday the European Medicines Agency granted the company a positive recommendation for approval of its treatment for a rare disorder that occurs in patients with cardiomyopathy. The drug,...
Read MoreDec 13, 2019
By Tamara Mathias (Reuters) – Shares of Sarepta Therapeutics Inc soared 32% on Friday after U.S. regulators shocked Wall Street by reversing their rejection of its muscle-wasting disorder therapy less than four months ago,...
Read MoreDec 13, 2019
By Kate Kelland LONDON (Reuters) – British drugmaker GSK applied on Friday for a license to...
Read MoreDec 13, 2019
By Stephanie Nebehay GENEVA (Reuters) – Cases of the deadly Ebola virus have risen in the Democratic Republic of Congo where health care workers remain largely cut off from the disease’s hotspots since militants...
Read MoreDec 13, 2019
ZURICH (Reuters) – A late-stage clinical trial has shown therapy combining Roche’s...
Read More